Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma

@inproceedings{Zhuang2015SerumMS,
  title={Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma},
  author={Liping Zhuang and Litao Xu and Peng Wang and Zhiqiang Meng},
  booktitle={PloS one},
  year={2015}
}
Circulating miRNAs are promising biomarkers for predicting the aggressiveness of hepatocellular carcinoma (HCC). We aimed to identify differentially expressed miRNAs in the serum of HCC patients with different Barcelona Clinic Liver Cancer (BCLC) stage, and to investigate the potential of serum miRNAs as biomarkers for patient outcomes. In the discovery stage, TaqMan Low-Density Array was used to test the difference in levels of serum miRNAs between 20 patients with portal vein tumor thrombosis… CONTINUE READING
Highly Cited
This paper has 17 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Similar Papers

Loading similar papers…